CryoStim™ treatment to begin FDA clinical trials
Immunovative Therapies, Ltd. recently announced that its New Drug (IND) application was cleared by the US Food and Drug Administration, allowing the company to begin clinical trials of its experimental CryoStim™ cancer vaccine product for the treatment of advanced metastatic solid tumors.





